Evidence map›Paper›PMID 39605186›Full record

ArticleAnnals of neurology2025

Unveiling the Clinical and Imaging Signatures of Intravascular Lymphoma of the Central Nervous System: A Multicentric Cohort Study.

Elodie Berthet, Antoine Guillonnet, Caroline Houillier, Renata Ursu, Carole Soussain, Mehdi Touat, Antoine Gueguen, Benoît de Renzis, Kevin Bigaut, Guido Ahle and 9 more

Abstract readMulticenter Study
In one paragraph

Article in Annals of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Elodie BerthetNeurology Departement, Lariboisière Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.ORCID 0009-0007-4385-7740
Antoine GuillonnetNeuroradiology Departement, Lariboisière Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
Caroline HouillierNeurooncology Departement, Pitié-Salpétrière Hospital, Assistance Publique-Hôpitaux de Paris, Sorbonne Université, Paris, France.
Renata UrsuNeurooncology Department, Saint-Louis Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
Carole SoussainDepartment of Hematology, Institut Curie, Site Saint-Cloud, France and INSERM U932 Institut Curie, PSL Research University, Paris, France.
Mehdi TouatNeurooncology Departement, Pitié-Salpétrière Hospital, Assistance Publique-Hôpitaux de Paris, Sorbonne Université, Paris, France.
Antoine GueguenDepartment of Neurology, Rothschild Ophthalmologic Foundation, Paris, France.
Benoît de RenzisDepartment of Hematology, CHU Clermont-Ferrand, Clermont-Ferrand, France.
Kevin BigautDepartment of Neurology, University Hospital of Strasbourg, Strasbourg, France.ORCID 0000-0002-5176-580X
Guido AhleDepartment of Neurology, Civilian Hospitals Colmar, Colmar, France.ORCID 0000-0002-0877-2289
Pierre DurozardDepartment of Neurology, Ajaccio Hospital, Ajaccio, France.ORCID 0000-0003-3459-7741
Deborah Grosset-JaninDepartment of Neurology, Annecy-Genevois Hospital, Epagny-Metz-Tessy, France.
Lucie ObericDepartment of Hematology, Cancer University Institute of Toulouse Oncopole, Toulouse, France.
Antoine BonnetDepartment of Hematology, Centre Hospitalier de Bretagne Atlantique, Vannes, France.
Anne-Pascale GrandjeanDepartment of Hematology, CHU Clermont-Ferrand, Clermont-Ferrand, France.
Cécile Moluçon-ChabrotDepartment of Hematology, CHU Clermont-Ferrand, Clermont-Ferrand, France.
Khê Hoang-XuanNeurooncology Departement, Pitié-Salpétrière Hospital, Assistance Publique-Hôpitaux de Paris, Sorbonne Université, Paris, France.
Hugues ChabriatTranslational NeuroVascular Centre, Lariboisière Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.ORCID 0000-0001-8436-6074
Stéphanie GueyTranslational NeuroVascular Centre, Lariboisière Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveIntravascular lymphoma is a rare subtype of B-cell lymphoma characterized by a clonal proliferation restricted to the lumen of small vessels. Over 50% of patients exhibit central nervous system (CNS) involvement, but diagnosis is often delayed due to the lack of distinctive features. We aimed to identify key phenotypic features for early diagnosis of intravascular lymphoma with CNS involvement through an in-depth cohort study.

methodsWe built up a multicenter retrospective cohort of 17 patients recruited in collaboration with the French Expert Network for Oculo-Cerebral Lymphomas (LOC network), and retrospectively analyzed data from medical records.

resultsIn this cohort, 15 of 17 (88%) patients developed focal neurological episodes, often fluctuating and/or recurrent, with a sudden onset in 68% of episodes, suggesting a vascular origin. Rapid cognitive deterioration occurred in 15 of 17 (88%) patients, psychiatric manifestations in 8 of 17 (47%), and "B signs" in 14 of 17 (82%). Brain MRI showed polymorphic FLAIR hyperintensities in 14 of 16 (87%) patients, and DWI-positive lesions in 13 of 16 (81%) of patients, which accumulated over time and had unusual characteristics for ischemic lesions (progressive growth, persistent DWI-hyperintensity over 1 month, surrounded by a wider FLAIR hyperintensity). Early-onset inflammatory syndrome, and elevated lactate dehydrogenase (LDH) levels were observed in over 90% of cases. Mild and inconsistent meningitis contrasted with a nearly-constant hyperproteinorachia. An increased interleukin 10/6 ratio over 0,7 was found in 4 of 7 (57%) patients, and skin biopsy led to a pathological diagnosis in 3 of 6 (50%) patients.

interpretationThe results of this study highlight "red flags" that could help accelerate the diagnosis of intravascular lymphoma involving the CNS. ANN NEUROL 2025;97:435-448.

Indexed as

Central Nervous System NeoplasmsLymphoma, B-CellVascular NeoplasmsAdultAgedAged, 80 and overCohort StudiesFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedRetrospective Studies

Identifiers

PMID39605186
PMCPMC11831878

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.